Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:18 PM
Ignite Modification Date:
2025-12-24 @ 4:18 PM
NCT ID:
NCT01425866
Eligibility Criteria:
Inclusion Criteria:
* Type 2 diabetes
* HbA1c ≥ 7,5% more than 3 months
* Adults
* ≥ 1 year ADO and/or insulin and/or GLP-1 analog
* antidiabetic treatment unchanged since 3 months (no change of treatment in the last 3 months, except for insulin dosage)
* Living in Reunion Island
* Affiliated to French national health insurance
* Signed informed consent
Exclusion Criteria:
* Treatment or associated conditions that would influence glycemic control, such as corticotherapy, cancer, inflammatory chronic diseases
* Hospitalisation linked to diabetes \< 3 months
* Structured patient education in the past 3 months
* Severe diabetes complications (e.g. ischemic or proliferative retinopathy, severe renal failure (clearance \< 15 ml/min), acute ischemic heart disease (\< 6 months, foot lesion)
* Pregnancy (on-going or planned during the study)
* Evolutive cancer
* Physical or cognitive heavy handicap
* Concomitant participation to a therapeutic trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01425866
Study Brief:
Protocol Section:
NCT01425866